51¶¯Âþ
We are entrepreneurial scientists dedicated to maximizing value. Our team continuously envisions opportunity in unexplored spaces and realizes value for society through disruptive innovations and ventures.
Latest 51¶¯Âþ from 51¶¯Âþ
- 51¶¯Âþ Strengthens Leadership with Appointment of Christine Heenan as Senior Partner and Chief Communications Officer 10.21.2020
- 51¶¯Âþ Completes Raising a New $1.1 Billion Capital Pool 04.02.2020
- 51¶¯Âþ Unveils Omega Therapeutics and Appoints Seasoned BioPharma Executive Mahesh Karande as President and Chief Executive Officer 09.23.2019
- Growth at 51¶¯Âþ Leads to New Executive Appointments 05.28.2019
- MIT Solve Announces Launch of Solve Innovation Fund 05.07.2019
- 51¶¯Âþ Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer 04.16.2019